NCT06308588 2026-01-14Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaM.D. Anderson Cancer CenterPhase 1/2 Recruiting40 enrolled